Trailing-twelve-month (TTM) revenue is $129,724 with a year-over-year growth of (97.99%). Revenue represents the total income generated from the company's primary business operations.
Trailing-12-month revenue adds these four fiscal quarters. Amounts are in USD, rounded only to whole currency units.
| Fiscal period | Revenue | Source |
|---|---|---|
| Q3 FY2025Period ended 2025-09-30 | $34,627 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2025-11-14 |
| Q4 FY2025Period ended 2025-12-31 | $36,551 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-03-18 |
| Q1 FY2026Period ended 2026-03-31 | $31,591 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-05-12 |
| Q2 FY2026Period ended 2026-06-30 | $26,955 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-08-12 |
| TTM revenue | $129,724 |
Current P/S: $14,458,172 market capitalization ÷ $129,724 TTM revenue = 111.45x.
Market capitalization source: FMP quote. Quote observed 2026-10-06T20:00:01.000Z. Latest revenue period ended 2026-06-30.
Current market capitalization comes from the quote provider. EPS weighted-average shares are a separate measure.
These references are supplied through FMP. Full filing context identifiers and dimensional metadata are unavailable in the normalized feed.
Reported quarterly revenue; no daily interpolation. Q2 FY2026 (2026-06-30): $26955.00.
FMP quote market capitalization / revenue from four consecutive issuer fiscal quarters Quote observation: 2026-10-06T22:27:08.239Z. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation. Historical series through 2026-10-05.
Selected amounts supplied by FMP for each displayed period. Reviewed label references appear where available; other labels are unverified, and items may overlap.
2025-12-31 · USD
Reviewed labels link to their filing; other labels are unverified FMP source labels.
Reviewed presentation labels and parent/child details link to filing evidence; other FMP source labels remain unverified. Mutual exclusivity and reconciliation to a total for the same reporting period and currency have not been verified; percentages and stacked totals are unavailable.
2024-12-31 · USD
Reviewed labels link to their filing; other labels are unverified FMP source labels.
FMP selected disclosures by reporting period. Rows match exact source labels; they may overlap. N/A means no matching disclosure, not zero. Filing links identify reviewed presentation labels for that period.
| FMP source label (unverified unless linked) | FY20182018-12-31 · USD | FY20252025-12-31 · USD |
|---|---|---|
| License | N/A | $116,900 |
| Product | $606,710 | $174,645 |
| Royalty | N/A | $28,169 |
FMP selected disclosures by reporting period. Rows match exact source labels; they may overlap. N/A means no matching disclosure, not zero. Filing links identify reviewed presentation labels for that period.
| FMP source label (unverified unless linked) | FY20192019-12-31 · USD | FY20202020-12-31 · USD | FY20212021-12-31 · USD | FY20222022-12-31 · USD | FY20232023-12-31 · USD | FY20242024-12-31 · USD |
|---|---|---|---|---|---|---|
| Australia | N/A | N/A | $1M | $688,000 | $526,000 | N/A |
| AUSTRALIA | N/A | N/A | N/A |
$129,724
$129,724
(97.99%)
vs. $6.45M a year ago (TTM)
(60.54%)
5 Year compound annual growth rate
1 Year
(97.99%)
3 Year
(76.84%)
5 Year
(60.54%)
10 Year
(13.62%)
15 Year
N/A
20 Year
N/A
CAGR shows the annualized growth rate over the specified period, smoothing out year-to-year volatility.
| Year | Revenue | YoY Change | % Change |
|---|---|---|---|
| 2025 | $319,714 | ($7.69M) | (96.01%) |
| 2024 | $8.01M | ($672,000) | (7.74%) |
| 2023 | $8.68M | ($2.56M) | (22.79%) |
| 2022 | $11.24M | ($2.36M) | (17.35%) |
| 2021 | $13.60M | +$2.30M | +20.36% |
| 2020 |
TTM Growth
(97.99%)
3-Year CAGR
(76.84%)
5-Year CAGR
(60.54%)
Revenue growth vs the same fiscal quarter in the prior fiscal year, last 33 comparable quarters.
Current FMP quote-based enterprise value / four-quarter revenue Quote observation: 2026-10-06T22:27:08.239Z. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation. Historical series through 2026-10-05.
Reviewed presentation labels and parent/child details link to filing evidence; other FMP source labels remain unverified. Mutual exclusivity and reconciliation to a total for the same reporting period and currency have not been verified; percentages and stacked totals are unavailable.
| N/A |
| N/A |
| $392,000 |
| Europe | N/A | $2M | $2M | $1M | $956,000 | $687,000 |
|---|
| Non Us | $2M | $114,000 | N/A | N/A | N/A | N/A |
|---|
| Non-US | N/A | N/A | N/A | N/A | N/A | $40,000 |
|---|
| Rest of world | N/A | N/A | $137,000 | $70,000 | $62,000 | N/A |
|---|
| U | $13M | $8M | N/A | N/A | N/A | N/A |
|---|
| United States | N/A | N/A | $10M | $9M | $7M | N/A |
|---|
| UNITED STATES | N/A | N/A | N/A | N/A | N/A | $7M |
|---|
| $11.30M |
| ($3.79M) |
| (25.12%) |
| 2019 | $15.09M | +$14.48M | +2387.02% |
| 2018 | $606,710 | ($680,444) | (52.86%) |
| 2017 | $1.29M | +$500,494 | +63.62% |
| 2016 | $786,660 | +$494,660 | +169.40% |
